5月30日 演題レポート

  • Colorectal Cancer
  • Non-Colorectal Cancer

CSS=Clinical Science Symposia / PDS=Poster Discussion Session

Abstract #LBA100


PD-1 Blockade in Tumors with Mismatch Repair Deficiency

Dung Le, et al.

Abstract #3504

切除不能大腸癌における2次予防*としてのアスピリンの影響:25,644例によるpopulation based study

Impact of Aspirin as Secondary Prevention in an Unselected Cohort of 25,644 Patients with Colorectal Cancer: A Population-based Study

Simer Bains, et al.

Abstract #3507

FOLFOX ± Cetuximabによる術後補助化学療法を受けたマイクロサテライト安定性 (MSS) stage III大腸癌のBRAF V600EとKRAS exon 2変異型の予後に与える影響: PETACC8試験、N0147試験の3,934例のプール解析

Prognostic Value of BRAF V600E and KRAS exon 2 Mutations in Microstatellite Stable, Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX ± Cetuximab: A Pooled Analysis of 3934 Patients from the PETACC8 and N0147 Trials

Julien Taieb, et al.

Abstract #3508

HER2陽性切除不能進行・再発大腸癌患者に対するTrastuzumabとLapatinibの併用療法:HERACLES trial

Trastuzumab and Lapatinib in HER2-amplified Metastatic Colorectal Cancer Patients (mCRC): The HERACLES Trial

Salvatore Siena, et al.

Abstract #LBA101

進行肝細胞癌に対するNivolumabの安全性と抗腫瘍効果を探索する第I/II相試験 (CA209-040試験)

Phase I/II Safety and Antitumor Activity of Nivolumab in Patients with Advanced Hepatocellular Carcinoma (HCC): CA209-040

Anthony B. El-Khoueiry, et al.